BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 9020569)

  • 1. Myasthenia gravis.
    Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of myasthenia gravis.
    Marx A; Wilisch A; Schultz A; Gattenlöhner S; Nenninger R; Müller-Hermelink HK
    Virchows Arch; 1997 May; 430(5):355-64. PubMed ID: 9174625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thymus in myasthenia gravis.
    Hohlfeld R; Wekerle H
    Neurol Clin; 1994 May; 12(2):331-42. PubMed ID: 8041345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thymic abnormalities in patients with myasthenia gravis].
    Utsugisawa K; Nagane Y
    Brain Nerve; 2011 Jul; 63(7):685-94. PubMed ID: 21747138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological aspects of malignant and benign thymic disorders.
    Müller-Hermelink HK; Marx A
    Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofilament expression in thymic epithelial tumors and anti-axonal autoantibodies in myasthenia gravis: a model for autoimmunity by abnormal T cell selection].
    Marx A; Kirchner T; Greiner A; Schalke B; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1992; 76():256-61. PubMed ID: 1283271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E; Klinkert WE; Wekerle H
    Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the thymus in the physiopathology of myasthenia].
    Eymard B; Berrih-Aknin S
    Rev Neurol (Paris); 1995 Jan; 151(1):6-15. PubMed ID: 7676132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunizing mechanisms in thymoma and thymus.
    Willcox N; Leite MI; Kadota Y; Jones M; Meager A; Subrahmanyam P; Dasgupta B; Morgan BP; Vincent A
    Ann N Y Acad Sci; 2008; 1132():163-73. PubMed ID: 18567866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
    Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
    Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells.
    Sommer N; Willcox N; Harcourt GC; Newsom-Davis J
    Ann Neurol; 1990 Sep; 28(3):312-9. PubMed ID: 2241114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis.
    Marx A; Kirchner T; Hoppe F; O'Connor R; Schalke B; Tzartos S; Müller-Hermelink HK
    Am J Pathol; 1989 Apr; 134(4):865-77. PubMed ID: 2468286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of molecules mediating thymocyte-stroma-interactions in human thymus, thymitis and thymic epithelial tumors.
    Marx A; Schömig D; Schultz A; Gattenlöhner S; Jung A; Kirchner T; Melms A; Müller-Hermelink HK
    Thymus; 1994; 23(2):83-93. PubMed ID: 7725387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
    Reinhardt C; Melms A
    Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
    Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
    J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.